NEWS
New Feature!!!! University Subject Rankings in 12 branches
FOR SCIENTIST REGISTRATION FOR INSTITUTIONAL BULK REGISTRATION
FOR EDIT YOUR UNIVERSITY / INSTITUTION PAGE
Some differences of the AD Scientific Index
New Feature!!!! University Subject Rankings in 12 branches
List without CERN, Statistical Data etc. Only in AD Scientific Index
New Feature!!!! University Subject Rankings in 12 branches
AD
Scientific Index 2024
About Us
Methodology
Compare & Choose
Contact - FAQ
login
Login
person_add
Register
school
University Rankings
subject
University Subject Rankings
place
Country Rankings
insights
i10 Productivity Rankings
insights
Subject Rankings
format_list_numbered
Top 100 Scientists
format_list_numbered
Citation Rankings
format_quote
Top 100 Institutions
local_fire_department
Country Top Lists
James L Gulley
AD Scientific Index 2024
Medical and Health Sciences / Immunology
National Institutes of Health - Bethesda, Maryland / United States
Edit Form
Registration, Add Profile,
Premium Membership
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
James L Gulley's MOST POPULAR ARTICLES
1-)
Androgen deprivation therapy for prostate cancerN Sharifi, JL Gulley, WL DahutJama 294 (2), 238-244, 200511372005
2-)
Overall survival analysis of a phase II randomized controlled trial of a Poxviral-based PSA-targeted immunotherapy in metastatic castration-resistant prostate cancerPW Kantoff, TJ Schuetz, BA Blumenstein, LM Glode, DL Bilhartz, ...Journal of Clinical Oncology 28 (7), 1099, 201011152010
3-)
Avelumab, an anti–programmed death-ligand 1 antibody, in patients with refractory metastatic urothelial carcinoma: results from a multicenter, phase ib studyAB Apolo, JR Infante, A Balmanoukian, MR Patel, D Wang, K Kelly, ...Journal of Clinical Oncology 35 (19), 2117, 20175542017
4-)
Avelumab in metastatic urothelial carcinoma after platinum failure (JAVELIN Solid Tumor): pooled results from two expansion cohorts of an open-label, phase 1 trialMR Patel, J Ellerton, JR Infante, M Agrawal, M Gordon, R Aljumaily, ...The Lancet Oncology 19 (1), 51-64, 20185962018
5-)
Antibody-dependent cellular cytotoxicity activity of a novel anti–PD-L1 antibody avelumab (MSB0010718C) on human tumor cellsB Boyerinas, C Jochems, M Fantini, CR Heery, JL Gulley, KY Tsang, ...Cancer immunology research 3 (10), 1148-1157, 2015586*2015
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept